Clinical trial demonstrates the ability of nVNS to accelerate sensorimotor learning in USAF Simulator Based Pilot Training ROCKAWAY, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the Air Force Research Laboratories (AFRL) presented new results supporting the ability of electroCore’s TAC-STIM (nVNS) to […]
Category Archives: Pr Newswire
10
Sep
Sep
Spectral AI’s DeepView® System Designed to Provide Equity in Burn Care Access While Optimizing Healthcare Resources DALLAS, Sept. 10, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today provided an […]
Pr Newswire
A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are
10
Sep
Sep
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue of how some of the largest pharmaceutical companies are reaching patients worldwide, especially in low- and middle-income countries (LMICs). Ahead of the 2024 Access to Medicine Index, the Foundation examined the […]
SINGAPORE, Sept. 10, 2024 /PRNewswire/ — LightInTheBox Holding Co., Ltd. (NYSE: LITB) (“LightInTheBox” or the “Company”), an apparel e-commerce retailer that ships products to consumers worldwide, announced that it will hold its annual general meeting of shareholders (the “AGM”) at the 11th Floor, 1188 Financial Center, No. 1188 Minsheng Road, Pudong New Area, Shanghai, People’s […]
BEIJING, Sept. 10, 2024 /PRNewswire/ — World-leading solar product maker Seraphim recently announced its 776 MW high-efficiency solar PV project portfolio under construction in southwest China’s Yunnan Province. Photo shows panoramic view of Seraphim’s solar PV project in southwest China’s Yunnan Province. (Provided by Seraphim) Encompassing six sub-projects spread across Chuxiong, Lincang, Qujing, and Guangnan […]
AMSTERDAM, Sept. 10, 2024 /PRNewswire/ — OCI Global (Euronext: OCI), (“OCI”, the “Company”), a leading global producer and distributor of hydrogen products today announced that it has reached agreement with Alpha Dhabi Holding PJSC (“ADH”) and ADQ to repurchase their 11% and 4% stakes respectively in OCI’s Global Methanol Business (“OCI Methanol” or “OCI Clean […]
ZHAOYUAN, China, Sept. 10, 2024 /PRNewswire/ — On September 9, Linglong Tire, a Chinese leading tire manufacturing company, officially announced a multi-year agreement with Chelsea Football Club, one of the world’s most prestigious football clubs, becoming the Official Tire Partner. Over the coming seasons, Linglong and Chelsea will create bespoke content & experiences in key […]
– Pharmacokinetic/pharmacodynamic (PK/PD) modeling data from three Phase 1 studies providing dosing support for upcoming clinical trials– Exposure-Response (E-R) Analysis showed a positive correlation between uliledlimab concentration and ORR probability in mNSCLC patients– Randomized Phase 2 study of uliledlimab in combination with pembrolizumab plus chemotherapy expected to begin in 1H 2025 ROCKVILLE, Md., Sept. 10, […]
Pr Newswire
MediciNova Announces Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial Accepted for Poster Presentation at the 35th International Symposium on ALS / MND
10
Sep
Sep
LA JOLLA, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that an abstract regarding a clinical trial of MN-166 (ibudilast) in the treatment of Amyotrophic Lateral Sclerosis (ALS), COMBAT-ALS study […]
Pr Newswire
UPDATE – Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
10
Sep
Sep
DOYLESTOWN, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced that Oren Gilad Ph.D, President and Chief Executive Officer, will deliver an in-person presentation at the H.C. Wainwright 26th Annual Global Investment Conference, taking place […]